Aclidinium bromide/formoterol

From WikiProjectMed
Jump to navigation Jump to search
Aclidinium bromide/formoterol
Combination of
Aclidinium bromideLong-acting muscarinic antagonist
FormoterolLong-acting β2 agonist
Clinical data
Trade namesBrimica Genuair, Duaklir Genuair, Duaklir Pressair
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
  • AU: B3
Routes of
administration
Inhalation
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • UK: POM (Prescription only) [1]
  • US: ℞-only [2]
  • EU: Rx-only [3][4]
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
  • 2446159-07-3
KEGG

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.[3][4]

References

  1. ^ "Duaklir Genuair 340 micrograms /12 micrograms inhalation powder - Summary of Product Characteristics (SmPC)". (emc). 9 September 2019. Retrieved 26 July 2020.
  2. ^ "Duaklir Pressair- aclidinium bromide and formoterol fumarte powder, metered". DailyMed. 3 July 2020. Retrieved 28 November 2020.
  3. ^ a b "Duaklir Genuair EPAR". European Medicines Agency (EMA). Retrieved 26 July 2020.
  4. ^ a b "Brimica Genuair EPAR". European Medicines Agency (EMA). Retrieved 26 July 2020.

External links